Hypothalamic orexin prevents hepatic insulin resistance induced by social defeat stress in mice

Neuropeptides

Volumn 47, Issue 3, 2013, Pages 213-219

  Tsuneki, Hiroshi ^a   Tokai, Emi ^a   Sugawara, Chieko ^a   Wada, Tsutomu ^a   Sakurai, Takeshi ^b   Sasaoka, Toshiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Depression; Hepatic insulin resistance; Hypocretin; Orexin; Type 2 diabetes

Indexed keywords

GLUCOSE; OREXIN; PROTEIN KINASE B; PYRUVIC ACID;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC RESTRICTION; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SOCIAL AVOIDANCE BEHAVIOR; SOCIAL DEFEAT STRESS; SOCIAL INTERACTION; SOCIAL STRESS;

ANIMALS; BLOTTING, WESTERN; CORTICOSTERONE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HYPOTHALAMUS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; PROTO-ONCOGENE PROTEINS C-AKT; PYRUVIC ACID; SOCIAL DOMINANCE; STRESS, PSYCHOLOGICAL;

MUS;

EID: 84878411022     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2013.02.002     Document Type: Article

References (42)

1. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006, 29:1130-1139.
2. Alldredge B. Pathogenic involvement of neuropeptides in anxiety and depression. Neuropeptides 2010, 44:215-224.
3. Andrikopoulos S., Blair A.R., Deluca N., Fam B.C., Proietto J. Evaluating the glucose tolerance test in mice. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1323-E1332.
4. Berridge C.W., España R.A., Vittoz N.M. Hypocretin/orexin in arousal and stress. Brain Res. 2010, 1314:91-102.
5. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
6. Blouet C., Schwartz G.J. Hypothalamic nutrient sensing in the control of energy homeostasis. Behav. Brain Res. 2010, 209:1-12.
7. Brundin L., Björkqvist M., Petersén A., Träskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur. Neuropsychopharmacol. 2007, 17:573-579.
8. Buhl E.S., Jensen T.K., Jessen N., Elfving B., Buhl C.S., Kristiansen S.B., Pold R., Solskov L., Schmitz O., Wegener G., Lund S., Petersen K.F. Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E920-E929.
9. Carter M.E., Borg J.S., de Lecea L. The brain hypocretins and their receptors: mediators of allostatic arousal. Curr. Opin. Pharmacol. 2009, 9:39-45.
10. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
11. Chuang J.C., Cui H., Mason B.L., Mahgoub M., Bookout A.L., Yu H.G., Perello M., Elmquist J.K., Repa J.J., Zigman J.M., Lutter M. Chronic social defeat stress disrupts regulation of lipid synthesis. J. Lipid Res. 2010, 51:1344-1353.
12. 3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress. Biol. Psychiatry 2010, 67:1075-1082.
13. Coppari R., Bjørbæk C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat. Rev. Drug Discov. 2012, 11:692-708.
14. Defronzo R.A. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58:773-795.
15. Fortuyn H.A., Mulders P.C., Renier W.O., Buitelaar J.K., Overeem S. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med. 2011, 12:714-719.
16. Funato H., Tsai A.L., Willie J.T., Kisanuki Y., Williams S.C., Sakurai T., Yanagisawa M. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 2009, 9:64-76.
17. Heydendael W., Sharma K., Iyer V., Luz S., Piel D., Beck S., Bhatnagar S. Orexins/hypocretins act in the posterior paraventricular thalamic nucleus during repeated stress to regulate facilitation to novel stress. Endocrinology 2011, 152:4738-4752.
18. Honda Y., Doi Y., Ninomiya R., Ninomiya C. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 1986, 9:254-259.
19. Knol M.J., Twisk J.W., Beekman A.T., Heine R.J., Snoek F.J., Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837-845.
20. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
21. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
22. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci. 2008, 28:3071-3075.
23. Marino J.S., Xu Y., Hill J.W. Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol. Metab. 2011, 22:275-285.
24. Mezuk B., Eaton W.W., Albrecht S., Golden S.H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-2390.
25. Nocjar C., Zhang J., Feng P., Panksepp J. The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus. Neuroscience 2012, 218:138-153.
26. Nouwen A., Nefs G., Caramlau I., Connock M., Winkley K., Lloyd C.E., Peyrot M., Pouwer F. European Depression in Diabetes Research Consortium. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011, 34:752-762.
27. Pan A., Keum N., Okereke O.I., Sun Q., Kivimaki M., Rubin R.R., Hu F.B. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012, 35:1171-1180.
28. Renn B.N., Feliciano L., Segal D.L. The bidirectional relationship of depression and diabetes: a systematic review. Clin. Psychol. Rev. 2011, 31:1239-1246.
29. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
30. Sakurai T., Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol. Sci. 2011, 32:451-462.
31. Salomon R.M., Ripley B., Kennedy J.S., Johnson B., Schmidt D., Zeitzer J.M., Nishino S., Mignot E. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry 2003, 54:96-104.
32. Schuld A., Hebebrand J., Geller F., Pollmächer T. Increased body-mass index in patients with narcolepsy. Lancet 2000, 355:1274-1275.
33. Scott M.M., Marcus J.N., Pettersen A., Birnbaum S.G., Mochizuki T., Scammell T.E., Nestler E.J., Elmquist J.K., Lutter M. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav. Brain Res. 2011, 222:289-294.
34. Silva N., Atlantis E., Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?. Curr. Psychiatry Rep. 2012, 14:8-14.
35. Timonen M., Rajala U., Jokelainen J., Keinänen-Kiukaanniemi S., Meyer-Rochow V.B., Räsänen P. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Mol. Psychiatry 2006, 11:929-933.
36. Tsuneki H., Murata S., Anzawa Y., Soeda Y., Tokai E., Wada T., Kimura I., Yanagisawa M., Sakurai T., Sasaoka T. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia 2008, 51:657-667.
37. Tsuneki H., Wada T., Sasaoka T. Role of orexin in the central regulation of glucose and energy homeostasis. Endocr. J. 2012, 59:365-374.
38. Uchida Y., Takeshita K., Yamamoto K., Kikuchi R., Nakayama T., Nomura M., Cheng X.W., Egashira K., Matsushita T., Nakamura H., Murohara T. Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1. Diabetes 2012, 61:1552-1561.
39. van den Pol A.N. Neuropeptide transmission in brain circuits. Neuron 2012, 76:98-115.
40. Yao X.H., Nyomba B.L. Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R1797-R1806.
41. Yi C.X., Serlie M.J., Ackermans M.T., Foppen E., Buijs R.M., Sauerwein H.P., Fliers E., Kalsbeek A. A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes 2009, 58:1998-2005.
42. Zhang S., Zeitzer J.M., Yoshida Y., Wisor J.P., Nishino S., Edgar D.M., Mignot E. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 2004, 27:619-627.